Skip to main content
. 2003 Jan 28;88(2):187–194. doi: 10.1038/sj.bjc.6600716

Table 3. Tumour response.

  Site
Response Nasopharynx Neck Overall
Clinical      
 CR 66 (73.3%) 64 (71.1%) 52 (57.8%)
 PR 23 (25.6%) 24 (26.7%) 36 (40.0%)
 SD 1 (1.1%) 2 (2.2%) 2 (2.2%)
       
Pathologicala      
 CR 55 (62.5%)    
 Residual tumour 33 (37.5%)    
a

A total of 88 out of 90 patients received rebiopsy of nasopharynx after neoadjuvant chemotherapy before radiotherapy.

CR=complete response, PR=partial response, SD=stable disease.